NICE’s new methods: putting innovation first, but at what cost?

28 November 2022 - Traditionally the gatekeeper to the NHS, NICE has increasingly reoriented its role towards facilitating access to innovative ...

Read more →

New Quality Innovation Expert Group supports medicine innovation

21 November 2022 - The EMA has established a Quality Innovation Expert Group to support innovative approaches for the development, ...

Read more →

An innovation surcharge to fund the repurposing of generic drugs

10 November 2022 - The use of generic drugs continues to increase, generating substantial savings for purchasers and improving affordable access ...

Read more →

Aleta Biotherapeutics receives Innovation Passport Designation for biologic CAR T-cell therapy engager ALETA-001

7 November 2022 - ALETA-001 was developed to address the urgent unmet need of patient relapse after CD19 targeted CAR ...

Read more →

Blue Earth Therapeutics awarded UK MHRA innovation passport for investigational 177Lu-rhPSMA-10.1 for treatment of metastatic castrate-resistant prostate cancer

8 November 2022 - Lutetium LU 177 labeled radiohybrid prostate specific membrane antigen (Lu 177-rhPSMA-10.1) is an optimised therapeutic radiopharmaceutical. ...

Read more →

FDA accepts Integral Molecular's letter of intent on membrane proteome array antibody specificity test into ISTAND drug development tools pilot program

7 September 2022 - Integral Molecular has been accepted into the US FDA's ISTAND pilot program.  ...

Read more →

The EU HTA regulation: a new frontier for access to innovative technologies

23 August 2022 - A new health technology regulation is due to be applied to help EU countries determine the effectiveness ...

Read more →

AstraZeneca's Soriot warns new US drug price law will hurt innovation

23 August 2022 - AstraZeneca's Chief Executive Pascal Soriot warned on Tuesday new US legislation capping drug prices would reduce ...

Read more →

Drug pricing reforms can hurt innovation. Here are 3 ways to prevent that.

22 August 2022 - Giving billions of dollars in government prize money to drug companies might sound like an idea from ...

Read more →

Regulatory considerations to keep pace with innovation in digital health products

19 August 2022 - Rapid innovation and proliferation of software as a medical device have accelerated the clinical use of digital ...

Read more →

Lurbinectedin receives the Innovative Medicine designation by the UK’s MHRA

5 August 2022 - PharmaMar has announced today that Zepzelca (lurbinectedin) has received the Innovation Passport (Innovative Medicine designation) by the ...

Read more →

Critics decry drug pricing provisions in Inflation Reduction Act, say they will stifle innovation

2 August 2022 - The push back against the prescription drug pricing provisions in the Inflation Reduction Act is relentless and ...

Read more →

'Government excessively controls drug prices, not recognising novel drugs' value'

15 July 2022 - The Government is wielding excessive power to lower drug prices without recognising the values ​​of innovative ...

Read more →

Revolo Biotherapeutics awarded Innovation Passport for ‘1805 in the United Kingdom for the treatment of moderate to severe rheumatoid arthritis

14 July 2022 - Revolo Biotherapeutics today announced that it was awarded an Innovative Medicines Designation, or Innovation Passport, from the ...

Read more →

The Innovative Medicines Fund - good news for patients but has an opportunity been missed to be more ambitious?

27 June 2022 - NHS England and Improvement has announced the launch of the Innovative Medicines Fund. The ABPI’s Director ...

Read more →